Lamivudine received FDA approval in 1995 [1].
What is Lamivudine used for?
Lamivudine is a nucleoside analog used to treat or prevent infections caused by certain viruses [2]. It is most notably used in combination therapies for HIV/AIDS and for the treatment of chronic hepatitis B [3][4].
When did Lamivudine's patent expire?
The original patents for lamivudine have expired, allowing for the production of generic versions [5]. Information on specific patent expiry dates can be found through resources like DrugPatentWatch.com [5].
How does Lamivudine work?
Lamivudine works by interfering with the enzymes that viruses need to copy themselves. In the case of HIV, it inhibits reverse transcriptase. For hepatitis B, it inhibits the virus's DNA polymerase [3][4]. This action prevents the virus from replicating and spreading within the body.
What are the side effects of Lamivudine?
Common side effects associated with lamivudine can include headache, nausea, diarrhea, fatigue, and muscle pain [6]. More serious, though less common, side effects can include pancreatitis and neuropathy [6]. Patients experiencing severe or persistent side effects should consult their healthcare provider.
Who makes Lamivudine?
Initially developed by Glaxo Wellcome (now GlaxoSmithKline), lamivudine is now manufactured by various pharmaceutical companies in its generic form [7].
What are the alternatives to Lamivudine for HIV treatment?
For HIV treatment, lamivudine is typically used as part of a combination antiretroviral therapy (cART). Many other antiretroviral drugs are available, belonging to different classes such as integrase inhibitors, protease inhibitors, and non-nucleoside reverse transcriptase inhibitors, which can be used in various combinations depending on individual patient needs and resistance profiles [8].
What are the alternatives to Lamivudine for Hepatitis B treatment?
For chronic hepatitis B, other antiviral medications are available, including entecavir, tenofovir disoproxil fumarate (TDF), and tenofovir alafenamide (TAF) [9]. The choice of treatment depends on factors like viral load, liver function, and resistance patterns [9].
Can Lamivudine be used during pregnancy?
The use of lamivudine during pregnancy is a complex decision made by healthcare professionals, weighing the potential benefits against any possible risks to the mother and fetus. Guidelines and recommendations for use in pregnancy can evolve [10].
What is the difference between Lamivudine and Emtricitabine?
Lamivudine and emtricitabine are both nucleoside reverse transcriptase inhibitors (NRTIs) used in HIV treatment and hepatitis B treatment. While they have similar mechanisms of action, they are distinct drugs with potentially different side effect profiles and resistance patterns [11][12]. Emtricitabine is often preferred in some HIV treatment regimens due to its longer half-life and potentially lower rates of certain side effects [11].
What is the clinical data on Lamivudine's effectiveness?
Extensive clinical trials have demonstrated the efficacy of lamivudine in suppressing viral replication for both HIV and hepatitis B, leading to improved health outcomes for patients [3][4]. Its inclusion in combination therapies has been a cornerstone of HIV treatment and a significant advancement in managing chronic hepatitis B.
What is the dosage for Lamivudine?
Dosages for lamivudine vary depending on the condition being treated and the patient's age and weight. For HIV, it is typically combined with other antiretrovirals. For hepatitis B, specific dosages are prescribed. It is crucial to follow the dosage instructions provided by a healthcare professional [3][4].
Sources:
1. https://www.fda.gov/
2. https://www.nhs.uk/
3. https://www.hiv.va.gov/
4. https://www.hhs.gov/
5. https://drugpatentwatch.com/
6. https://www.mayoclinic.org/
7. https://www.glaxosmithkline.com/
8. https://www.aidsinfo.nih.gov/
9. https://www.hcvadvocate.org/
10. https://www.ncbi.nlm.nih.gov/
11. https://www.rxlist.com/
12. https://www.verywellhealth.com/